I. J. Christensen

2.6k total citations
49 papers, 2.2k citations indexed

About

I. J. Christensen is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, I. J. Christensen has authored 49 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 16 papers in Cancer Research and 12 papers in Molecular Biology. Recurrent topics in I. J. Christensen's work include Protease and Inhibitor Mechanisms (11 papers), Peptidase Inhibition and Analysis (7 papers) and Colorectal Cancer Surgical Treatments (5 papers). I. J. Christensen is often cited by papers focused on Protease and Inhibitor Mechanisms (11 papers), Peptidase Inhibition and Analysis (7 papers) and Colorectal Cancer Surgical Treatments (5 papers). I. J. Christensen collaborates with scholars based in Denmark, United Kingdom and United States. I. J. Christensen's co-authors include Hans Jørgen Nielsen, M Blichert-Toft, K Danø, Christian Rosenquist, J Grøndahl-Hansen, H.T. Mouridsen, S Bülow, F Moesgaard, Mads Holten-Andersen and Nils Brünner and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

I. J. Christensen

48 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. J. Christensen Denmark 24 1.2k 930 481 460 293 49 2.2k
Yutaka Ogata Japan 20 832 0.7× 494 0.5× 509 1.1× 288 0.6× 160 0.5× 98 1.6k
Yasuyuki Hirashima Japan 26 542 0.5× 406 0.4× 319 0.7× 557 1.2× 100 0.3× 81 1.8k
Yoshinari Ogawa Japan 21 885 0.8× 729 0.8× 472 1.0× 862 1.9× 41 0.1× 83 2.1k
Guido Nicolò Italy 29 951 0.8× 644 0.7× 512 1.1× 987 2.1× 43 0.1× 94 2.9k
Ali Amirkhosravi United States 27 720 0.6× 307 0.3× 274 0.6× 685 1.5× 898 3.1× 62 2.5k
Frank A. Scappaticci United States 22 1.4k 1.2× 470 0.5× 271 0.6× 1.2k 2.6× 102 0.3× 38 2.8k
Trilok Parekh United States 24 1.3k 1.1× 314 0.3× 365 0.8× 875 1.9× 478 1.6× 64 2.6k
Susan C. Guba United States 22 1.3k 1.1× 350 0.4× 178 0.4× 675 1.5× 191 0.7× 49 2.4k
Dahish Ajarim Saudi Arabia 26 1.4k 1.2× 527 0.6× 239 0.5× 609 1.3× 81 0.3× 88 2.4k
James D. Reimann United States 12 967 0.8× 347 0.4× 209 0.4× 607 1.3× 99 0.3× 16 3.0k

Countries citing papers authored by I. J. Christensen

Since Specialization
Citations

This map shows the geographic impact of I. J. Christensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. J. Christensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. J. Christensen more than expected).

Fields of papers citing papers by I. J. Christensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. J. Christensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. J. Christensen. The network helps show where I. J. Christensen may publish in the future.

Co-authorship network of co-authors of I. J. Christensen

This figure shows the co-authorship network connecting the top 25 collaborators of I. J. Christensen. A scholar is included among the top collaborators of I. J. Christensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. J. Christensen. I. J. Christensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Christensen, I. J., et al.. (2018). Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018). Pediatric Rheumatology. 16(S2). 16 indexed citations
2.
3.
Stenvang, Jan, Marcel Smid, Søren Drud-Heydary Nielsen, et al.. (2012). Abstract P3-06-32: Topoisomerase 1 gene copy aberration is a frequent finding in clinical breast cancer samples. Cancer Research. 72(24_Supplement). P3–6. 2 indexed citations
4.
Bülow, S, I. J. Christensen, Jan Björk, et al.. (2011). Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis. Colorectal Disease. 14(8). 947–952. 52 indexed citations
6.
Ytting, Henriette, I. J. Christensen, R. Steffensen, et al.. (2010). Mannan‐Binding Lectin (MBL) and MBL‐Associated Serine Protease 2 (MASP‐2) Genotypes in Colorectal Cancer. Scandinavian Journal of Immunology. 73(2). 122–127. 24 indexed citations
7.
Bülow, S, et al.. (2006). Transanal stent in anterior resection does not prevent anastomotic leakage. Colorectal Disease. 8(6). 494–496. 41 indexed citations
8.
Larsen, Mette Bach, Ross W. Stephens, Nils Brünner, et al.. (2005). Quantification of Tissue Inhibitor of Metalloproteinases 2 in Plasma from Healthy Donors and Cancer Patients. Scandinavian Journal of Immunology. 61(5). 449–460. 20 indexed citations
9.
Svendsen, Mads Nordahl, K. Werther, I. J. Christensen, Linda Basse, & Hans Jørgen Nielsen. (2005). Influence of open versus laparoscopically assisted colectomy on soluble vascular endothelial growth factor (sVEGF) and its soluble receptor 1 (sVEGFR1). Inflammation Research. 54(11). 458–463. 9 indexed citations
10.
Holten-Andersen, Mads, I. J. Christensen, Mef Nilbert, et al.. (2003). Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival. European Journal of Cancer. 40(1). 64–72. 46 indexed citations
11.
Ottesen, Gyda Lolk, H.P. Graversen, M Blichert-Toft, I. J. Christensen, & Johan A. Andersen. (2000). Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Breast Cancer Research and Treatment. 62(3). 197–210. 78 indexed citations
12.
Holten-Andersen, Mads, Gillian Murphy, Hans Jørgen Nielsen, et al.. (1999). Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. British Journal of Cancer. 80(3-4). 495–503. 128 indexed citations
14.
Wilson, L.D., Donald Rosenthal, I. J. Christensen, et al.. (1998). The influence of extracorporeal photopheresis (ECP) in addition to total skin electron (TSE) therapy on disease-free and cause-specific survival in patients with erythrodermic (T4) mycosis fungoides (MF) and the sezary syndrome. International Journal of Radiation Oncology*Biology*Physics. 42(1). 131–131. 1 indexed citations
15.
16.
Christensen, I. J., et al.. (1995). Progesterone Receptor Levels Independently Predict Survival in Endometrial Adenocarcinoma. Gynecologic Oncology. 59(3). 347–351. 28 indexed citations
18.
Biering‐Sørensen, Fin, et al.. (1991). Effect of respiratory training with a mouth-nose-mask in tetraplegics. Spinal Cord. 29(2). 113–119. 17 indexed citations
19.
Andersen, Jørn, Susan M. Thorpe, William King, et al.. (1990). The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assays. European Journal of Cancer and Clinical Oncology. 26(4). 442–449. 63 indexed citations
20.
McNatty, K. P., et al.. (1985). Steroid concentrations in fluid from human ovarian antral follicles during pregnancy. Journal of Endocrinology. 107(1). 133–136. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026